Viral Vector News and Research

RSS
Viral Vector is a type of virus used in cancer therapy. The virus is changed in the laboratory and cannot cause disease. Viral vectors may produce tumor antigens (proteins found on a tumor cell) to stimulate an antitumor immune response in the body. Viral vectors may also be used to carry genes that can change cancer cells back to normal cells.
MVA SARS-CoV-2 vaccine candidate shows strong immunogenicity in preclinical trials

MVA SARS-CoV-2 vaccine candidate shows strong immunogenicity in preclinical trials

Could intranasal SARS-CoV-2 vaccines be a practical alternative to intramuscular shots?

Could intranasal SARS-CoV-2 vaccines be a practical alternative to intramuscular shots?

Atmospheric particulate matter may influence the transmission and evolution of SARS-CoV-2

Atmospheric particulate matter may influence the transmission and evolution of SARS-CoV-2

Gene therapy can effectively treat mice with tuberous sclerosis complex, shows study

Gene therapy can effectively treat mice with tuberous sclerosis complex, shows study

Thermo Fisher announces construction of new cGMP plasmid DNA manufacturing facility

Thermo Fisher announces construction of new cGMP plasmid DNA manufacturing facility

New data shows encouraging results for patients with neuro-degenerative blinding eye disease

New data shows encouraging results for patients with neuro-degenerative blinding eye disease

Interim results show Oxford COVID-19 vaccine protects against symptomatic disease

Interim results show Oxford COVID-19 vaccine protects against symptomatic disease

A new potential COVID-19 vaccine candidate: YF-S0

A new potential COVID-19 vaccine candidate: YF-S0

Genethon to start international clinical trial for treatment of Duchenne muscular dystrophy

Genethon to start international clinical trial for treatment of Duchenne muscular dystrophy

Oxford University and AstraZeneca release their COVID-19 vaccine results

Oxford University and AstraZeneca release their COVID-19 vaccine results

New understanding of glycan signatures of the SARS-COV-2 S1 spike protein

New understanding of glycan signatures of the SARS-COV-2 S1 spike protein

Repairing brain damage caused by MS

Repairing brain damage caused by MS

UH and CWRU announce Phase 3 trial of Astrazeneca's investigational COVID-19 vaccine

UH and CWRU announce Phase 3 trial of Astrazeneca's investigational COVID-19 vaccine

Phase 1 trial results of gorilla adenovirus vaccine for COVID-19

Phase 1 trial results of gorilla adenovirus vaccine for COVID-19

Design of an mRNA SARS-CoV-2 vaccine encapsulated in lipid nanoparticles

Design of an mRNA SARS-CoV-2 vaccine encapsulated in lipid nanoparticles

Mass production of SARS-CoV-2 ORF8 protein using a chemical-inducible system in tobacco BY-2 cells

Mass production of SARS-CoV-2 ORF8 protein using a chemical-inducible system in tobacco BY-2 cells

People infected with other types of coronaviruses may have less severe COVID-19 infection

People infected with other types of coronaviruses may have less severe COVID-19 infection

J&J's COVID-19 vaccine shows potent immune response in phase 2 human trial

J&J's COVID-19 vaccine shows potent immune response in phase 2 human trial

OXGENE launches a scalable, plasmid-free manufacturing system for AAV

OXGENE launches a scalable, plasmid-free manufacturing system for AAV

Oxford University and AstraZeneca resume COVID-19 vaccine trial

Oxford University and AstraZeneca resume COVID-19 vaccine trial